Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. EBITDA 2015–2022
Aptevo Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2015 to 2022. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Aptevo Therapeutics Inc. ebitda for the quarter ending March 31, 2022 was -5.4 M, a 18.58% decrease year-over-year.
- Aptevo Therapeutics Inc. ebitda for the twelve months ending March 31, 2022 was -35.7 M.
- Aptevo Therapeutics Inc. annual ebitda for 2022 was -27.7 M, a 36.95% increase from 2021.
- Aptevo Therapeutics Inc. annual ebitda for 2021 was -20.3 M, a 22.36% decrease from 2020.
- Aptevo Therapeutics Inc. annual ebitda for 2020 was -26.1 M, a 32.64% decrease from 2019.
- Aptevo Therapeutics Inc. annual ebitda for 2019 was -38.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aptevo Therapeutics Inc. EBITDA — FAQ
Aptevo Therapeutics Inc. (APVO) ebitda over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see APVO's ebitda history?
The chart and table above show Aptevo Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.